<DOC>
	<DOCNO>NCT00128726</DOCNO>
	<brief_summary>The purpose study determine safety efficacy continuous combine oral contraceptive pill ( CCOCP ) regimen . The investigator hypothesize decrease number vaginal bleeding day continuous regimen compare traditional 21/7 regimen . In addition , investigator hypothesize increase endometrial ovarian suppression CCOCP regimen .</brief_summary>
	<brief_title>The Effects Continuous Administration Monophasic Oral Contraceptive Bleeding Days Endometrial Ovarian Function</brief_title>
	<detailed_description>In U.S. many woman reproductive age use form contraception , 23 % use estrogen-progesterone combined oral contraceptive . Low-dose oral contraceptive suppress ovulation dominant follicle selection inhibit luteinizing hormone follicle stimulate hormone secretion pituitary gland . Under social , cultural religious influence , woman traditionally prescribed oral contraceptive pattern 21 day active pill seven day inactive pill way mimic natural menstrual cycle provide reassurance absence pregnancy withdrawal bleed placebo period . However , withdrawal bleeding occur placebo period may still present debilitate menstrual symptom cramp , spot break bleeding , menstrual migraine anemia . These menstrual disorder remain one common reason prescribe oral contraceptive . Suppression bleed discard seven placebo tablet advocate woman severe mental disability impair hygiene proper use , well occasional use woman inconvenience menstruation ( i.e . female athlete competition woman military ) . Additionally , many physician use oral contraceptive pill regimens treat endometriosis , premenstrual syndrome , anovulatory dysfunctional uterine bleeding , acne , hirsutism anemia . The seven day pill free ovarian axis ovarian follicular development increase ovarian sex steroid production may result mild exacerbation treat condition . There grow patient preference avoid vaginal bleeding completely , pre-menopausal post-menopausal hormone replacement regimens general population . This reflect woman 's attitude change menstrual bleeding pattern assess 1996 Dutch survey . The majority woman study age group say would prefer decrease frequency bleed less month completely eliminate menses altogether use oral contraceptive . Therefore , reduce bleed day important goal improve quality life woman suffer discomfort inconvenience withdrawal bleeding .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy woman legal age consent 1835 year wish use continuous combined oral contraceptive nonsmoker . Must regular ( 2531 ) day menstrual cycle three month period precede enrollment . Subject comply protocol , opinion investigator . Thrombophlebitis Known suspect clot disorder Cerebrovascular coronary artery disease myocardial infarction Malignancy Known suspect estrogen dependent neoplasia Undiagnosed abnormal genital bleed Benign malignant liver tumor develop use oral contraceptive estrogencontaining product Hyperlipidemia fast cholesterol level great 6.73 mmol/L ( 260mg ) ; fast triglyceride level great 3.39 mmol/L ( 300mg/dl ) ; high cholesterol . Diabetes mellitus Migraine increase sensitivity headache previous estrogen oral contraceptive study Depression require hospitalization associate suicidal ideation Chronic renal disease Known hypersensitivity estrogens and/or progestogen Neuroocular disorder Cholestatic jaundice Pregnancy take oral contraceptive Persistent non compliance take medication Serious adverse experience oral contraceptive use Malabsorption due illness surgery Use experimental drug device within last 90 day study drug administration Any anticonvulsant medication Any use rifampin within 3 month enrollment Any use lipid lower agent Impaired liver function disease Known suspect pregnancy Hypertension whether treat untreated Cervical cytological smear low grade squamous intraepithelial lesion ( SIL ) great untreated within last year The use intrauterine device ( IUD ) injectable implantable estrogen , progestogen , androgen six month period enrollment ; oral contraceptive sex hormone use within three cycle enrollment . Breast feed Known suspect alcoholism drug abuse Smoking</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>continuous combine oral contraceptive</keyword>
	<keyword>endometrial ovarian suppression</keyword>
</DOC>